🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to complete the total safety database size for...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-07-19
Trial ID
NCT03954743
The purpose of this study is to evaluate the immunogenicity, reactogenicity...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-02-20
Trial ID
NCT02141204
Treatments Being Tested
This protocol posting deals with objectives and outcome measures of the pri...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-02
Trial ID
NCT00750893
Treatments Being Tested
This study is conducted to demonstrate non-inferiority in the immunogenicit...
Status
Completed
Location
CDC Nam Dinh
Start Date
2019-03-16
Trial ID
NCT03703336
Treatments Being Tested
To assess the long-term efficacy and safety of the subjects during the thir...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-12
Trial ID
NCT00420316
Treatments Being Tested
This study will provide data on the immune response and safety of GSK Biolo...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03-09
Trial ID
NCT00432380
The purpose of this study is to evaluate the immunogenicity and safety of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-09-16
Trial ID
NCT02907216
Treatments Being Tested
The study will evaluate safety and immunogenicity of LORV (Rotarix and RV3-...
Status
Completed
Location
Wits RHI Shandukani Research Centre
Start Date
2021-02-22
Trial ID
NCT04344054
Treatments Being Tested
The purpose of this study is to evaluate the clinical consistency of three ...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-10-27
Trial ID
NCT02914184
Treatments Being Tested
The purpose of this study is to evaluate the immune response and safety of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2024-03-22
Trial ID
NCT06331156
Treatments Being Tested